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Pancreatic cancer is one of the most lethal human can-
cers and continues to be a major clinical problem, even
in the 21st century [1]. It rarely develops in the first five
decades of life [2,3]. Pancreatic cancer may initially
present with dull epigastric pain radiating to the back,
along with weight loss or jaundice; however, pan-
creatitis is not included in the list of common clinical
manifestations. In this report, we describe a young man
in whom relapsed acute pancreatitis was the initial
feature of subsequently confirmed pancreatic cancer
with multiple metastases. To our knowledge, this is the
youngest case of pancreatic cancer with the uncom-
mon initial feature of acute pancreatitis to be reported
in the literature.
CASE PRESENTATION
A 31-year-old man without any remarkable family his-
tory of systemic disease or malignancy and without
any remarkable past medical history, except for smok-
ing 0.5 packs per day and alcohol consumption (on
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In this report, we describe a 31-year-old man in whom acute pancreatitis was the initial feature of
a subsequently diagnosed pancreatic adenocarcinoma with multiple metastases. He initially pre-
sented at our hospital with acute pancreatitis. Abdominal ultrasonography revealed a mildly dilated
pancreatic duct and an enlarged pancreatic head. Although a follow-up abdominal ultrasonography
revealed a progressively dilated pancreatic duct and a progressively enlarged pancreatic head, 
he refused further investigation and was lost to follow-up. Four months later, he returned to our
hospital with relapsed acute pancreatitis. Obstructive jaundice was noted and drainage was 
performed. Because choledochoplasty with multiple balloon catheters was not fully effective, 
biliary tract bypass surgery was carried out. Intraoperative biopsy confirmed pancreatic adeno-
carcinoma with multiple metastases. The patient died of massive gastrointestinal bleeding a few
weeks later. To our knowledge, this is the youngest case of pancreatic cancer with the uncommon
initial presentation of acute pancreatitis reported in the literature. For a patient with acute pan-
creatitis, particularly recurrent episodes, but with no known risk factors for pancreatitis, 
a pancreatic neoplasm should be considered as a potential underlying cause, even in a young man.
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average, about 700mL of beer, 3 times a week) for more
than 10 years, presented at the emergency department
of our hospital owing to intermittent abdominal pain
in the left upper quadrant over 2 days. He reported
having some sensation of acid regurgitation and hun-
ger pain for several days, but he denied experiencing
any nausea, vomiting or diarrhea. He was afebrile,
with normal vital signs, a soft abdomen without any
abdominal tenderness, and hyperactive bowel sounds.
Because his clinical presentation and plain abdominal
roentgenogram suggested stool impaction, he was
discharged with the prescription of some laxatives.
He returned to the emergency department 2 days
later with nausea and worsened abdominal pain in the
left upper quadrant and epigastric area. His abdomen
was still soft, but tender in the left upper quadrant.
Acute pancreatitis was diagnosed based on elevated
serum lipase level (970 IU/L; normal, 7–58 IU/L) and
computed tomography (CT) findings (Figure 1A). He
rejected admission owing to a rapid resolution of 
abdominal pain soon after management performed
in the emergency department.
Six days later, he returned to the emergency depart-
ment because of severe abdominal pain with radiation
to the back after consumption of about 350 mL of beer.
His vital signs were normal and his abdomen was soft
with normoactive bowel sound. Laboratory tests re-
vealed a persistently elevated (although lower than
that 6 days earlier) serum lipase level of 411 IU/L. He
was admitted under the diagnosis of acute pancreatitis.
Abdominal ultrasonography performed during hos-
pitalization showed a mildly dilated pancreatic duct
and an enlarged pancreatic head. He was discharged
11 days later after successful conservative treatment.
At a follow-up visit at our outpatient department
5 days later, he reported experiencing mild abdomi-
nal pain after a heavy meal which subsided after a few
days. His serum lipase level at that time was 423 IU/L.
An elevated carbohydrate antigen 19-9 (CA19-9)
level (82.8 U/mL; normal, < 37 U/mL) was also noted.
A B
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Figure 1. Contrast-enhanced axial abdominal computed tomog-
raphy revealed (A) a swollen pancreas with relatively poor
enhancement, surrounded by inflammatory infiltration (arrows)
initially. The pancreatic duct was mildly dilated. (B) Six months
later, a progressively swollen head and uncinate process of the
pancreas (*) with poor enhancement, surrounded by peripancre-
atic inflammatory infiltration (arrows) and focal fluid collection
was observed. Progressive dilatation of the pancreatic duct and
emerging nodules (arrowhead) with soft tissue density in the peri-
pancreatic region were also noted. (C) Seven months later, pro-
gressive enlargement of the irregular hypodense mass lesion in the
head and uncinate process of the pancreas (*) with poor enhance-
ment, as previously noted, was observed and was later confirmed
to be pancreatic cancer. Progressive dilatation of the pancreatic
duct, increasing nodules (arrowheads) in the peripancreatic region
and the mesenteric spaces, and emerging hypodense nodules in
the liver (not shown) were also noted.
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Follow-up abdominal ultrasonography about 1 month
later revealed a progressively dilated pancreatic duct
and an enlarged pancreatic head. He refused further
CT investigation and was lost to follow-up.
He returned to the emergency department 4 months
later due to intermittent abdominal pain in the epi-
gastric area and in the periumbilical area with radiat-
ing pain to his back. He reported that the intermittent
abdominal pain started after a heavy meal with a large
amount of beer before this visit. He denied having
anorexia, postprandial pain or diarrhea. His serum
lipase level was 567 IU/L at this time. Relapsed acute
pancreatitis was diagnosed, based on the elevated
serum lipase level and CT findings (Figure 1B). He was
readmitted to our hospital for conservative treatment
and was discharged 8 days later with good tolerance
to a soft diet.
Five days later, he reported dull epigastric pain
and diarrhea after a large meal. He also noticed that
he was becoming icteric and passing dark urine, but
without clay-colored stool. He did not have fever,
chills or tenderness in the right upper quadrant of his
abdomen. He was readmitted for further investigation
and management. Laboratory examination showed
elevated levels of total bilirubin (9.00 mg/dL; nor-
mal, 0.2–1.0 mg/dL), direct bilirubin (5.42 mg/dL;
normal, 0–0.2 mg/dL), serum aspartate aminotrans-
ferase (347 U/L; normal, 10–35 U/L), serum alanine
aminotransferase (668U/L; normal, 10–40U/L), serum
alkaline phosphatase (321 U/L; normal, 32–92 U/L),
serum γ-glutamyl transferase (171 U/L; normal, 7–
64 U/L), serum lipase (326 IU/L), and serum amylase
(299 U/L; normal, 63–123 U/L). Abdominal ultraso-
nography revealed dilatation of the common bile duct,
common hepatic duct and gallbladder. Percutaneous
transhepatic biliary drainage was performed to relieve
his jaundice. Percutaneous transhepatic cholangiog-
raphy revealed complete obstruction of the distal com-
mon bile duct. External compression by pancreatitis
or pancreatic cancer was considered.
Follow-up abdominal CT (Figure 1C) revealed fur-
ther enlargement of the pancreatic head lesion with
lymphadenopathy and a few hepatic nodules. Thus
pancreatic cancer with liver metastases and lymph-
adenopathy was suspected.
Choledochoplasty with multiple balloon cathe-
ters was performed to dilate the distal common bile
duct, but the follow-up cholangiography 1 week later
showed narrowing of the previously dilated distal 
common bile duct. Two weeks later, extensively long
(> 3 cm) segmental stenosis of the distal common bile
duct was noted during the sequential revision of the
draining tube. Therefore, he was referred to our surgi-
cal department for pancreatic biopsy and for the pos-
sibility of biliary tract bypass surgery. Elevated serum
levels of CA19-9 (1,822.3U/mL) and carcinoembryonic
antigen (12.0 ng/mL; normal, 0–5 ng/mL) were noted
on the day before the operation. Multiple nodules on
the omentum and liver surface were found during the
operation. Excisional biopsy of the pancreatic head
tumor and nodules on the omentum and liver was
carried out. Choledochojejunostomy, Roux-en-Y an-
astomosis, gastrojejunostomy, and T-tube choledo-
chostomy were performed. Pathological examination
of the surgical specimens (Figure 2) confirmed pan-
creatic adenocarcinoma with metastases to the liver
and omentum. He was discharged 2 weeks after the
operation.
Two days after discharge, he presented at the
emergency department with hematemesis. Esopha-
gogastroduodenoscopy showed suspected duodenal
invasion of the pancreatic cancer with ulceration and
hemorrhage. Endoscopic biopsy could not be perfor-
med at that time owing to the possibility of inducing
further bleeding. He was admitted for further manage-
ment with blood transfusion, proton pump inhibitors
and sucralfate. He was discharged 19 days later with
no evidence of hemorrhage. However, 3 weeks later,
the hematemesis recurred. Emergency esophagogas-
troduodenoscopy failed to localize the source of bleed-
ing due to the large amount of fresh blood that had
accumulated in the prepyloric area and fundus. The
patient died of massive bleeding the next day.
DISCUSSION
Pancreatic cancer is a devastating disease with poor
prognosis, an overall 5-year survival rate of less than
1%, and a medium survival of approximately 5–6
months after tumor detection [4]. In Taiwan, it is the
eighth leading cause of cancer-related deaths in men
and the seventh in women [5]. It is now ranked fourth
as the cause of death from cancer in the United States,
Europe, and Japan, and is second only to colorectal
cancer as a cause of digestive cancer-related death [2,6].
Many risk factors for pancreatic cancer have been
identified, including old age, male sex, family history,
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chronic pancreatitis, obesity, low physical activity, 
a “Western” dietary pattern (high intake of fat and/or
meat, particularly smoked or processed meats), and
cigarette smoking [1,3,6–9]. However, the only risk fac-
tors to be consistently reported are age and cigarette
smoking [1,8]. Smoking was the only risk factor noted
in our case. The risk for developing pancreatic cancer
increases with age, with a mean age of onset in the sev-
enth and eighth decades of life [9]. Pancreatic cancer
rarely develops before the age of 50, but the inci-
dence rises sharply thereafter [2,3]. Our patient was
only 31 years old. About 5–10% of patients have a
family history of pancreatic cancer and seem to pres-
ent earlier than sporadic cases [3]. Certain syndromes
with a specific germline may increase the risk of pan-
creatic cancer. For example, a recent study showed that
the risk of pancreatic cancer was increased in families
with germline DNA mismatch repair gene mutation, as
compared with the general population [10]. Although
no malignancy was noted in the family members of our
patient, it is possible that genetic factors may have
played a role in the carcinogenesis of this case at this
young age.
The initial presentations of pancreatic cancer vary
according to tumor location [1–3]. Abdominal pain,
weight loss, jaundice and the development of diabetes
mellitus have been reported as the initial presenta-
tions for pancreatic cancer [1–3]. Abdominal pain is
often felt as a dull ache in the upper abdomen and may
radiate to the back, and often improve on leaning for-
ward [3]. Uncommonly, such pain may be severe and
transient, along with associated hyperamylasemia,
A
C
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Figure 2. (A) Tissue specimens from the pancreas showed nests of cancer cells and neoplastic glands infiltrating in the fibrotic tissue
(hematoxylin and eosin; original magnification, 20×). (B) Immunohistochemical stains revealed diffuse positive reactions for cytoker-
atin 7 (original magnification, 20×) and carcinoembryonic antigen, but were negative for CK20. (C) Liver tissue specimens showed
hepatic parenchyma with neoplastic glands (hematoxylin and eosin; original magnification, 20×), (D) which revealed diffuse positive
reaction with cytokeratin 7 (original magnification, 20×) and CK20, but was negative for hepatocyte stain. Similar neoplastic glands
were found in the tissue specimen from the omentum. The features were consistent with pancreatic adenocarcinoma with metastases to
the liver and omentum.
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indicating acute pancreatitis caused by substantial
ductal obstruction by tumor [1,3,11,12]. Our case ini-
tially presented with this uncommon manifestation.
At the first admission, abdominal ultrasonography
and CT showed a mildly dilated pancreatic duct and
an enlarged pancreatic head. These findings were con-
sidered to be caused by tissue swelling as a result of
the inflammatory process, but no definitive pancreatic
tumor could be found.
An elevated serum CA19-9 level and progressive
dilatation of the pancreatic duct with an enlarged
pancreatic head noted on ultrasonography after the
episode of pancreatitis subsided might suggest super-
imposed pancreatic cancer. Follow-up CT performed
after resolution of acute pancreatitis would be useful
to evaluate the possibility of superimposed cancer or to
locate the suspected lesion for biopsy. Unfortunately,
this patient did not accept our suggestion and was
lost to follow-up. As in the first CT scan, the second and
third CT scans were also performed during episodes
of pancreatitis. The findings of these scans could still
be explained by the process of pancreatitis but could
be used to diagnose superimposed cancer.
Magnetic resonance imaging is becoming more
widely used for acute pancreatitis. A recent study
showed no differences in the ability to detect acute
pancreatitis between diffusion-weighted imaging, an
increasingly used sequence of magnetic resonance
imaging, and CT imaging [13]. However, diffusion-
weighted imaging can detect acute pancreatitis more
clearly than CT without using enhancing material
and can detect pancreatic cancer as a cause of acute
pancreatitis [13]. Meanwhile, magnetic resonance cho-
langiopancreatography can detect choledocholithiasis
and pancreas divisum as a cause of acute pancreatitis
and can offer an alternative to endoscopic retrograde
cholangiopancreatography, at least for diagnosis [13,14].
Although CA19-9 is frequently elevated in patients
with various benign pancreaticobiliary disorders, it is
still useful for diagnosis of pancreatic cancer [2,15–18].
Since its first description in 1979, studies have sug-
gested that a serum concentration > 37 U/mL repre-
sents the most accurate cutoff value for discriminating
pancreatic cancer from benign pancreatic disease,
with a sensitivity of up to 90% and a specificity ap-
proaching 98% [9,16–19]. In practice, a very high
CA19-9 level (e.g. > 1,000 U/mL) along with a clinical
presentation consistent with pancreatic cancer is essen-
tially diagnostic for malignancy and is often associated
with surgically unresectable disease [2,9,19]. The pre-
operative serum CA19-9 level in our patient was
1,561.5 U/mL, which was compatible with his unre-
sectable disease.
For patients presenting with liver nodules and an
obvious pancreatic mass, liver biopsy offers an appro-
priate alternative method for diagnosis, and the diag-
nosis of pancreatic cancer with liver metastasis is
acceptable when the liver biopsy reveals adenocarci-
noma [1]. A recent study showed that ultrasound-
guided percutaneous pancreatic biopsy, as compared
with metastatic liver tumor biopsy, is an effective and
safe modality for confirming the pathologic diagnosis
in patients with unresectable pancreatic cancer [20].
In clinical practice, however, a CT-guided biopsy of
pancreatic tumor is more widely performed because
air interference limits the utility of ultrasound-guided
biopsy. Endoscopic ultrasound-guided fine-needle
aspiration has recently emerged as a diagnostic adjunct
for pancreatic lesions [21]. In a large, well-controlled
study, endoscopic ultrasound-guided fine-needle aspi-
ration with aspiration cytology was an accurate test
for detecting pancreatic adenocarcinoma [22]. Some
experts have also advocated biliary biopsy via tran-
shepatic tracts when performed during percutaneous
biliary drainage [23]. In our patient, because bypass
surgery was warranted for the extensively long seg-
mental stenosis of the common bile duct, preoperative
image-guided biopsy was not arranged. Furthermore,
image-guided biopsy was difficult to perform in this
patient because it was not easy to differentiate between
tumor tissue and inflammatory tissue on images.
Therefore, we arranged an intraoperative biopsy for
our patient.
Immunohistochemistry is often useful to reach 
a diagnosis of a malignancy. Cytokeratin (CK) 7 and
CK20 expression was present in 96% and 63% of cases
of pancreatic adenocarcinoma, respectively [24]. CK20
is an excellent marker for metastatic pancreatic cancer
[25] and overexpression of CK20 indicates a subtype
of pancreatic adenocarcinoma with decreased overall
survival [24,26]. Therefore, metastatic adenocarcinoma
of the liver positive for both CK20 and CK7, as in our
case, indicates that the primary tumor was localized
in the pancreaticobiliary system [27].
In addition to traditional treatment with bypass
surgery, biliary stricture may also be treated by stent-
ing. Percutaneous metallic biliary stenting was shown
to provide good palliation for malignant jaundice [28].
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However, owing to a lack of data on long-term pa-
tency, the use of metallic endobiliary stents for the
treatment of benign biliary strictures remains contro-
versial [29,30]. Some experts have even suggested
that metallic endobiliary stents should not be used
for benign strictures in patients with a predicted life
expectancy > 2 years [29]. Furthermore, lesions such
as strictures due to chronic pancreatitis are more dif-
ficult to treat, and endoscopic therapy with gradual
dilation and insertion of multiple plastic stents is re-
served for patients who are not candidates for surgery
[31]. In our case, no definitive evidence was available
to determine whether the stricture of the common bile
duct was caused by a benign disorder or by a malig-
nancy. Therefore, placement of a biliary stent was not
indicated owing to his young age and the diagnostic
uncertainty.
Invasive pancreatic cancer as a cause of massive
gastrointestinal hemorrhage is exceedingly rare [32–
35]. Mechanisms responsible for massive gastrointes-
tinal hemorrhage caused by a pancreatic tumor may
include gastric variceal hemorrhage secondary to sp-
lenic vein occlusion [36–39], a fistula from the blood
vessel to the duodenum (wirsungorrhage), direct tumor
hemorrhage via the pancreatic duct (hemosuccus), or
hemorrhage from the tumor invading into the gastro-
intestinal tract [32–35]. In a review of 859 endoscopies
in patients with upper gastrointestinal hemorrhage,
only three patients had a pancreatic tumor invading
the duodenum [40]. Furthermore, patients with mas-
sive gastrointestinal hemorrhage from invasive pan-
creatic cancer usually present with hematochezia or
tarry stool, rarely with hematemesis, as in our patient
[32,34].
Despite the recent advances in early diagnosis and
surgical treatment, the prognosis of patients with pan-
creatic cancer has not improved substantially. Surgical
resection is the only potentially curative treatment.
Unfortunately, due to the late presentation of the dis-
ease and the early dissemination of tumor cells, only
15–20% of patients are candidates for pancreatectomy,
and the prognosis of pancreatic cancer is even dis-
couraging in those with potentially resectable disease
[2]. To date, the 5-year survival rate for adenocarci-
noma of the pancreas is less than 5%, and most patients
die within the first 2 years [9]. Therefore, further stud-
ies are needed to identify high risk individuals, to
develop strategies for early detection, and to optimize
treatments.
In conclusion, we report a young man with ad-
vanced pancreatic cancer and multiple metastases who
initially presented with relapsing acute pancreatitis, an
uncommon initial presentation for pancreatic cancer.
Although young cases of pancreatic cancer have been
reported before [41,42], to our knowledge, this is the
youngest case of pancreatic cancer presenting ini-
tially with relapsing acute pancreatitis. For a patient
with acute pancreatitis, particularly one who has re-
current bouts and who has no known risk factors for
relapsing pancreatitis, a pancreatic neoplasm should
be considered as a potential underlying cause, even
in a young man.
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我們報告一個 31 歲男性以急性胰臟炎為其胰臟腺癌的初始表現。病人起初是因急性
胰臟炎來本院求診，腹部超音波發現胰臟頭部稍微腫大及胰管稍微擴大，且在追蹤下
更加明顯。然而病人拒絕進一步詳檢且不再回診。四個月後，病人再次因急性胰臟炎
來本院求診。不久，因阻塞性黃疸的現象而接受引流管置放。由於氣球擴張術效果不
佳，病人接受膽道繞道手術。術中所做的切片檢查證實是胰臟腺癌併多處轉移。病人
於術後數週後因大量胃腸道出血而過世。由文獻搜尋，這是我們所知最年輕以此一初
始表現的個案。急性胰臟炎的病人，特別是有反覆性發作且沒有其他的危險因子，即
使是年輕男性，仍然需要考慮胰臟腫瘤的可能性。
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